Hormone therapy may prevent -- or contribute to -- dementia risk

Nov 19, 2010 By Shari Roan

Hormone therapy appears to affect the brain differently depending on the age of the woman when she receives it, researchers reported Thursday.

Hormone-replacement therapy for women has been the subject of considerable debate. Studies have shown both pros and cons. But use has declined in the last decade because a major study on the issue, the Women's Health Initiative, found that the risks of taking hormones appeared to outweigh significantly the benefits in older . Among the findings was that beginning in women ages 65 and older led to a twofold higher risk of .

Questions remain about the effect of hormones if taken at a younger age - among perimenopausal (the phase before when hormones decline and fluctuate) or menopausal women in their early 50s. The new study, published in the Annals of Neurology, supports the idea that hormones can affect dementia risk differently depending on the age of the woman when she takes them.

Kaiser Permanente researchers examined data from members in Northern California from 1964 to 1973, among women 40 to 55 years old. The study examined whether hormones were used at midlife - defined in this study by the average age of 48.7 - or in late life, defined as age 76. Compared with women who never used hormones, those taking hormones only at midlife had a 26 percent decreased risk of dementia. This link held true even when the researchers controlled for other factors that contribute to dementia, such as high and stroke.

However, taking hormones in late life may counteract whatever benefits are seen by taking hormones at midlife, the authors said. Women taking hormone therapy only in late life had a 48 percent increase in dementia. Women using hormones at both midlife and late life did not differ in their dementia risk from women who didn't take hormones.

"The reduced risk of dementia associated with midlife hormone therapy use only lends support to the notion that it is not only early postmenopausal use of hormone therapy that is protective, but that use should also be limited to a few years," the authors wrote.

Animal studies suggest that estrogen benefits health, and observational studies have shown that women who take hormones are less likely to develop dementia later in life. But studies such as the Women's Health Initiative dashed hopes that hormones protected against cognitive impairment. Research now is focusing on whether there is a "critical window" for use - a specific time of life when hormones would do more good than harm.

Explore further: Cooling of dialysis fluids protects against brain damage

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Hormone replacement helps young women

Jan 26, 2007

The benefits of short-term hormone replacement therapy likely outweigh the risks for younger women, the Ohio-based North American Menopause Society said.

Recommended for you

Presence of peers ups health workers' hand hygiene

2 hours ago

(HealthDay)—The presence of other health care workers improves hand hygiene adherence, according to a study published in the October issue of Infection Control and Hospital Epidemiology.

Sierra Leone streets deserted as shutdown begins

10 hours ago

Sierra Leone's normally chaotic capital resembled a ghost town on Friday as residents were confined to their homes for the start of a three-day lockdown aimed at halting the deadly Ebola epidemic.

Sierra Leone launches controversial Ebola shutdown

11 hours ago

Sierra Leone on Friday launched a controversial three-day shutdown to contain the deadly spread of the Ebola virus, as the UN Security Council declared the deadly outbreak a threat to world peace.

User comments : 0